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OPENING REMARKS 
 
by  The Unit Convenor, Dr. J.R. Day. 
Department of Curriculum Studies, The University of Hong Kong. 
 
 
 The University of Hong Kong is pleased to welcome you to this colloquium to set in 
motion an initiative prompted by the problems of substance abuse in Hong Kong. With the 
help of the British Council, without which we could not have begun, it has been possible to 
equip a unit which will allow free exchange, via direct data transfer and facsimile, of 
information related to drug abuse and addictive behaviours and research into these topics, 
both within Hong Kong and from international sources. It will also allow us to bring to Hong 
Kong two or perhaps three experts in fields of substance abuse research. The first of these, 
Dr. Colin Drummond is here with us over the forthcoming fortnight. 
 
 Hong Kong has had programmes of treatment and rehabilitation for its heroin addicts 
for 30 years. It treats such addicts humanely by allowing them to maintain their addiction yet 
remain productive through the methadone programme, and it rehabilitates drug-using 
criminals through the Drug Addiction Treatment Centres within our prisons. In addition such 
programmes as those of S.A.R.D.A. allow voluntary clients to try to cease their habits. 
 
 However, in recent years, and in common with the rest of the world, Hong Kong has 
experienced a rapid increase in poly-drug abuse, and an increase in use by the young. 
Prosperity has brought a greater demand for alcohol from younger sections of the community 
and tobacco, although declining in use amongst older people, is increasing in use by the 
young, particularly by young women.  
 
 There has been no attempt to develop a concerted research programme to investigate 
problems or to review the reasons behind increasing abuse in Hong Kong. Despite a total of 
0.8% of the population who are heroin addicts, no work has been done to 
6 OPENING REMARKS 
investigate closely the pressures in this society which makes heroin the  apparent drug of 
choice. The reasons for frequent relapses  which reduce the effectiveness of rehabilitation 
programmes have not been investigated. 
 
 Therefore, we meet here today to begin the process of establishing lines of research 
and priorities for such a programme, to be co-ordinated through this Unit, but linking 
together all of the institutions where research might be carried out in such a way that funding 
may be applied for in a professional manner, funding sources may be investigated and 
requests for funded research can be received, to be offered to interested researchers. 
 
 It is hoped that this colloquium will have brought together all of those who wish to 
take an interest in such research, but if you know of others who are not here, please 
encourage them to attend one of the four seminars which Dr. Drummond, our guest today, 
will lead during the next two weeks. He will, of course, also be having smaller group 
meetings with groups from government and the caring professions concerned with substance-
abuse matters. 
 
 Dr. Drummond has a background of leadership and development in the Addiction 
Research Unit of the Institute of Psychiatry in London, now established as Britain's National 
Addiction Research Centre. We welcome him, and all of you to what will be, I hope, the first 
of a productive series of meetings in the revived area of drug addiction research for Hong 
Kong. 
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OPENING ADDRESS 
WHAT ARE WE TRYING TO DO? 
 
by Dr. D.C. Drummond, M.D., Ch.B., F.R.C.Psych.  
 
 
 I am delighted to be a part of this important and historic event in HK: the opening of 
the Drug Addiction Research Unit, (DARU). It is important and historic in a number of 
respects to which I will return in a moment. But first of all I feel it important to point out that 
I may not survive this evening's formalities and festivities. 
 
 I should explain that I have literally just got off a plane from London and feel 
somewhat jet lagged. Had it not been for Jeffrey Day's persuasive persistence, which 
incidentally ought to come in extremely useful in the years to come here, I would have very 
readily opted for R & R rather than this R & D! That is rest and recreation rather than 
research and development! Nevertheless, here I am, but if I might be somewhat 
presumptuous of my hosts, I would be extremely grateful that should I lapse into sleep during 
this opening address, someone would without too much fuss, place a blanket over me and 
give me a call for breakfast! 
 
 During the remaining time before such an undesirable somnolent state overtakes me I 
would like to make a few comments by way of introduction to this auspicious opening and 
also to introduce myself to Hong Kong. 
 
 In many ways the DARU here at The University of Hong Kong is retracing some of 
the early tentative steps taken by the research unit in London to which I belong. Clearly, 
there are many differences between the two settings which betray any attempts at 
comparison: this is 1991 and not 1963, this is a bustling cosmopolitan city in the East and not 
a crumbling Victorian inner city area of London, and the problems which face today's 
research workers have changed immeasurably from the time that my colleague Griffith 
Edwards began the pioneering work for which he is so rightly famous. 
 Nevertheless, there might be some lessons which can be learned from the other side 
of the world. Having joined the Addiction Research Unit many years after its inception  I am 
probably much less qualified than many to draw such parallels, but tonight I will attempt to 
ask a difficult question: 
 
 
What are we trying to do? 
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 This question is not meant in a facetious sense of implying that we in London, or 
anyone else in the Addiction Research field are devoid of direction or purpose in our 
endeavours, or indeed to suggest that what we are doing is without substance or merit. But 
rather, I aim to ask a difficult, but important question which must echo through every 
discussion, every teaching seminar, every research study and in every encounter with those 
affected by the devastation brought by addiction. Nor would I claim to have a definitive 
answer to this question. 
 
 What I will say is that, if we are not prepared to really address this question, we are in 
serious danger of setting off on the wrong tack, of following through our own pet interests 
and in the process, risk overlooking those issues which society desperately requires us to 
address. The consequences of such a scenario does not, I am sure require to be rehearsed. It 
seems, however, we seldom get more than one opportunity to get it right. The most 
optimistic aspect of the present developments here at the University of Hong Kong which we 
are here tonight to celebrate is that you have an excellent opportunity to begin a fresh thrust 
of endeavour in a field which has eluded some of the greatest minds of this and previous 
centuries. 
 
 In attempting to answer my question, I am going to focus on just three areas in which 
I feel we as a research community in the addictions field have a responsibility to lead the 
way. I am sure that every person in this room will have an even longer, and probably even 
more considered and much more worthy list of overriding objectives. But for what it is worth 
here are my three. 
 
So, what are we trying to do? 
1. Achieving Understanding. 
 
 Without understanding the nature of the problems related to addictive substances that 
we are dealing with we will be unable to fulfil any of our obligations. To achieve this we 
need to bring all the powers of science, reasoning, scholarship, and humility to bear on our 
chosen field of endeavour. Without this we will be thrashing around in the darkness of bias 
and personal prejudice. The history of the addictions field is littered with examples of the 
failings of costly initiatives based on inadequate knowledge. 
 
 As scientists we must bring objectivity to the problems brought by drug and alcohol 
addiction, which attract opinions, some with more merit than others from almost every 
person in society. If you want to assess this point, ask a London taxi driver. This is where I 
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obtain a sense of prevailing public attitudes. During recent journeys in central London I have 
learned that what addicts need is variously punishment, isolation, hypnosis, drug therapy, 
acupuncture and being sent to Australia. All worthy suggestions I am sure! But while it goes 
without saying that anyone is entitled to an opinion, if we are going to improve the lot of 
those affected by drug and alcohol problems we need to rise above the level of prejudice and 
try to begin to understand the nature of the problems through scientific study. 
 
 In formulating a shopping list of what is worthy research we need, however, to be 
selective. Part of the purpose of my visit here is to in some small way assist you in this 
process. In doing so I would like to share with you a quotation from a recent publication 
which discussed the Addiction Research Unit in London's philosophy on this matter, 
expressed in the eloquent prose of my colleague Griffith Edwards. 
 
"If a relatively small research team is to have any worthwhile impact in a world 
where it is competing nationally for scant funds and internationally with far bigger 
research battalions, it must take the job of determining the selective focus of its 
research programme with immense seriousness. It is insufficient that a topic should 
be merely 'interesting' that some member of staff personally likes doing that type of 
research, or that a question has recently been attracting media or political attention. 
 
 With theory based research there is merit in trying to target on issues which are 
perceived as having central and pervasive qualities of importance, while at the applied level 
the targeting should be on research which can potentially offer findings which are tangibly 
applicable to the problems of the real world. A research group should be willing to raise and 
grapple with these questions of choice, rather than leaving the setting of the research agenda 
to accident or drift." 
 
 So clearly, in Edwards' view, the lure of individual prejudice has to be resisted in 
deciding what should be researched. 
 
2. Relieving suffering. 
 
 My second point is connected with this, namely that we need to make our work 
applicable to the real world problems. Without applicability to the real world our work will 
be viewed as being of little value. But I would go further by saying that there is a strong need 
also to bear in mind the plight of those affected by the problems associated with addiction. 
What might seem a pragmatic or effective solution to a problem may be a long way from 
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providing needed relief to the sufferer. Herein lies the lure of unitary, sweeping solutions to 
complex problems. 
 
To cite two examples: 
 
 Raising the tax on alcohol by say 10% may, and indeed probably will, reduce the 
prevalence of alcohol problems in society. Such is the evidence from numerous 
epidemiological studies throughout the world. But at the same time it is only too easy to 
overlook how this measure might affect the very severely dependent alcoholic. While his 
lighter drinking counterparts have been persuaded by such a measure to reduce their alcohol 
consumption to a safer level and thus avoid problems, the man who up until now has 
managed to retain a patina of respectability and acceptance within society may be forced 
towards crime, the bottle gangs on skid row and further breakdown of his personal standards. 
By the same token, targeting help for only the small minority of the most severely affected 
drinkers stands to overlook the substantial benefits of reduced per capita consumption.  
 Similarly, the increased criminalization of drug use, with, as the London taxi driver 
would have us accept, the wholesale incarceration of drug takers, might go some way, 
probably only a very limited way, towards removing the problem from the streets into the 
prisons, but will have the unwanted effects of breaking up the drug users' social networks, his 
family, his job and so on, while at the same time exposing him to a greater risk of contracting 
H.I.V. infection through the increased sharing of scarce injecting equipment in prison. 
 
 So, we need at all times to temper our "big ideas" for ridding the world of addiction 
with an attempt to understand the problem from the affected individual's point of view. 
 
3. Education 
 
 Finally, the third on my shopping list of objectives is that of education. We, as a 
research community, can do little if we overlook this objective. Our research findings, our 
thoughts, and our aspirations will come to nought and be confined to the dusty shelves of 
some forgotten part of the library, awaiting rediscovery in another century by historians of 
ancient history. How excited they will be to find, as has often been the case in my own 
studies, that the same well-trodden paths are returned to over and over again by subsequent 
generations oblivious to the findings, as well as of course the mistakes, of our forebears. 
 
 Education, however, in this context does not apply to the small and select minority of 
students who will be fortunate enough to find their way into the esteemed confines of the 
Universities and colleges on specialized addiction courses. I am referring to dissemination of 
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knowledge to those who influence society as well as members of that society itself. Until we 
can make an impact on attitudes towards addiction and its treatment, with that recalcitrant 
and opinionated London taxi driver, with the person who has the problem themselves, to 
their family doctor, their employer, their husband or wife, we will not be able to rest content 
in our efforts. 
 
 The next generation of addiction researchers must be able to learn from our 
achievements as well as our mistakes. But above all there will be no next generation of 
addiction researchers unless we grasp the nettle and continually be prepared to ask ourselves 
"what are we trying to do?" 
 
In conclusion 
 
 I would like you to accept from both myself and my colleagues in London our warm 
congratulations on what has been achieved so far in Hong Kong, and I wish you every 
success in your endeavours here. 
 
 Over the next few days I am hoping to assist in any way I can with the planning of 
this exciting project, and of course my willingness to help extends far beyond this 
preliminary exchange. You can be assured that the developments here will be followed with 
great interest from around the world and particularly from London over what I anticipate to 
be many years of fruitful research. 
  
 Moreover I look forward to being able in the years to come to reflect on this event as 
a bright new dawn for addiction problems in Hong Kong, and indeed further afield.  
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HOW NOT TO ERADICATE DRUG ADDICTIONS 
 
by Karl Schmidt, M.D., F.R.C.Psych., etc. 
Administrative Head, Dept of Psychiatry, 
Suri Seri Begawan Hospital, 
 Brunei Darrussalam. 
 
 
 This paper describes the various ways in which drug addictions can remain 
established in communities forever.  It is somewhat cynical.  In the first part are described 
the numerous conferences over the last 21 years which the author has attended both in South-
East Asia and European countries as well as in Australia.  From over-view it would appear 
that very little progress has been made towards eradication of drug addictions.  It looks as if 
much of the material presented to the 26 International and National meetings, including 
psychiatric conferences with sections on drug addictions has been repetitive and, as it were, 
only nibbling on the subject, certainly as regards eradication of addictions.  It is tempting to 
conclude that eradication of drug addiction has not been a major concern of the many 
organizations involved, of the presenters of papers nor of the conference organizers since 
there has not been one single section anywhere, to the author's knowledge, devoted to the 
subject.  A tendency to avoid discussions of the subject of eradication has been palpable, 
almost as if one is ashamed to mention it. 
 
 The principles of preventing eradication of addiction can be classified into 
methodological and organizational ones. 
 
 As regards the first it is necessary, if one wants to avoid eradication of drug addiction 
not to use programmes which are ECONOMICAL, particularly those that only need an 
admission period of one month.  With long admission periods it can be safely predicted that 
there will never be enough facilities, personnel and funds available to catch up, as it were, 
with the problem, "a fairly safe bet". 
 
 Equally important is it to avoid programmes which show with presently available 
experience that a relapse rate within 2 years need not be more than 10%.  In other words, 
EFFECTIVE programmes, with the above criterion for EFFECTIVENESS, were better 
avoided. 
 
 Lastly programmes which show much ACCEPTABILITY are also better avoided.  To 
give two examples in this context, the first is "cold turkey" which might appear to be 
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unacceptable because it is not very humane to let somebody suffer from 10 -14 days when 
this is not necessary.  Furthermore "cold turkey" safely reinforces the addiction since the 
mind of the addict is only occupied by "I need a fix". 
 
 Secondly, methadone is equally effective in preventing eradication of addictions and 
therefore quite safe since it comfortably converts one addiction into another one.  Methadone 
would therefore be unacceptable in a program that aims at eradication. 
 
 Also COMPREHENSIVE programmes were better avoided, that is those which 
provide multiple instruments of self-help to the addicts, that is elements which train in life-
changes and in contents of thinking. 
 
 What has to be avoided most is a systems-approach to addiction; that is one which 
stands a good chance of changing the treatment-system by an element from outside the 
present system of addiction management.  In other words one which demands "more of the 
same" is better chosen!  We know from strategic psychotherapy that a system cannot be 
changed by demanding more facilities practising the same treatment elements and techniques 
which have failed epidemiologically within.  In a programme which the writer has been 
connected with that outside element which is brought to bear on the system in addiction 
management is Brain Electro-stimulation Transcutaneously (B.E.S.T.). 
 
A systems approach to addiction treatment utilising B.E.S.T. (Brain Electro-Stimulation 
Transcutaneouly). 
 
 Approximately 40 years ago the concept of homoeostasis was proposed with the 
central concept of negative feed-back or self-righting mechanism. 
 This systems concept was introduced in due course about 20 years ago also into 
psychotherapy, largely that brand of it which is called strategic psychotherapy. 
 
 Addiction management has, over the 21 years of the author's experience with it, not 
been able to lead to epidemiological change; that is either reducing or abolishing prevalence. 
 
 In fact it appears that most treatment systems, methodologies or strategies have not 
been designed with the goal of producing epidemiological change.  What has been practised 
is giving "more of the same" that is more treatment facilities, more staff, more funds, more 
counselling etc.  From systems theory and strategic psychotherapy (Erickson; Weakland, 
Watzlawik and others) we know that a system cannot be changed in this way.  It needs an 
outside element from another plane. 
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 It appears that all presently practised methods of drug addiction management have 
failed.  The reasons are: 
 
1) ECONOMY: 
 
The presently practised methods are uneconomical because they demand an 
admission-time of more than one month.  For that reason alone the prevalence of drug 
addiction can not be significantly lowered and no eradication can be considered since 
facilities will never be sufficient to allow this on purely economical grounds.  Also 
where more than one month admission is practised, usually a Drug Culture develops, 
that is thinking and talking about drugs. 
 
2) EFFECTIVENESS: 
 
The methods practised are ineffective in that relapse rates are usually much above 
10% within 2 years; the latter might be considered permissible. 
 
 
3) ACCEPTABILITY: 
 
The methods practised are unacceptable because they are either converting one 
addiction into another one such as is the case with methadone and therefore do not 
really touch problems of drug addiction.  Others are also unacceptable for the reason 
that no treatment is given for the withdrawal symptoms such as is the case where the 
so called "Cold Turkey" is practised.  The so called "Cold Turkey" is non-treatment 
and unfortunately reinforces the addiction.  The relapse rate with this method will 
always be unacceptably high. 
 
 Therefore one looks for alternatives.  They appear to be very few.  The approach 
which we have developed abolishes the above 3 restrictions for effective treatment & 
therefore allows for eradication. 
 
 
A Method that Allows for Eradication in a given Community. 
 
 In the program we have developed there are 12 elements; the outside and new 
element is B.E.S.T. or Brain Electro-Stimulation Transcutaneously.  This is an entirely 
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physical element without drugs, reducing if not abolishing withdrawal symptoms within 
hours and thereby making the addict accessible from day one for the other treatment 
elements. Many of the elements form parts of other treatment systems.  
 
 The 12 elements are: 
1. Contract 
2. B.E.S.T. 
3. One hour daily therapeutic counselling 
4. Four prescribed readings 
5. Religious counselling, so far always accepted 
6. 15 physical relaxation exercises twice daily (Yoga-like) 
7. Mental relaxation exercises twice daily (Medication-like) 
8. "Family" therapy 
9. Occupational therapy 
10. One to one relationship ("Buddy-system") 
11. Anti-Epileptic Medication may be necessary for one week on abrupt drug 
withdrawal 
12. 18 acu-pressure exercises 
 
 and, where necessary, anti-ictal drugs (especially after alcohol and diazepines).  Follow-up 
is for 2 years, 3 times weekly with urine drug screening. Admission to this very tightly 
packed program is for one month only. Our relapse rate within 2 years has been 10%. 
 
   The program is characterized by ECONOMY, EFFECTIVENESS, (only 10% 
percent relapse in 2 years) and ACCEPTABILITY. No "Cold Turkey", methadone or 
naltrexone are used. 
  
 The essential element of our approach is Brain-Electro-Stimulation Transcutaneously 
or B.E.S.T.  It has the advantage to abolish or modify withdrawal symptoms & takes the 
craving away usually within hours so that the other eleven elements of the program can be 
started with on day one of admission for treatment of addiction.  It's modus operandi is 
mobilization of endorphines suppressed by the drug addiction.  Speedy detoxification within 
hours appears to be occurring allowing for implementation of the other programme elements. 
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Seminars to Elucidate Research Directions for the Drug Addiction Research Unit. 
From 4th October to 11th October, a series of four seminars, led by Dr. Drummond, were 
given to attempt to elucidate possible lines of research for the Drug Addiction Research Unit. 
The following notes summarise these seminars.  
 
 
 
SEMINAR ON TREATMENT & RELAPSE  
 
FRIDAY 4TH. OCTOBER 1991. 
 
 
 Dr. Colin Drummond of the National Addiction Centre spoke of his work and other 
international research on the effectiveness of different treatment regimes on recovery 
outcomes for substance abusers. 
 
 Using mainly studies on alcohol abusers as a model, he indicated the scale of 
economic loss brought to the community in terms of medical expenses, premature death and 
reduced productivity caused by users of harmful substances. No research was available on 
losses due to young users who were able to take up only low value work after their addiction 
episodes, but who might have been more valuable to themselves and the community had 
problems related to addiction been prevented. While alcohol misuse was taken as the 
principal model to illustrate his points because of the greater availability of relevant data, Dr. 
Drummond emphasized the generalizability of the concepts to other substances: 
 
He reported the cost of alcohol misuse in Britain, (pop. approx. 56 million) as GBP 
1.6 billions per year. Costs related to tobacco where a third of the population smoke 
were reported as GBP312-535 millions depending on method of calculation.  
 
 Evidence was also given to show that chronic liver disease had doubled in prevalence 
between 1965 and 1989 in the U.K. 
 
 It was estimated that there were 75,000 severely dependent alcoholics, and that 10% 
of the population had alcohol-related problems. 
 
In addition, there were estimated to be 100,000 addicted to heroin and other illegal 
drugs, and 1 million addicts to benzodiazepines. 
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 He likened the problem for all drug abusers to a volcano, with a defined number in 
the cone of severe addiction to any substance, the majority at the base with no significant 
problem, but a large, unknown number climbing the slopes and slipping in and out of casual 
usage, at varying frequencies. The important point is that drinking problems merge 
imperceptibly into severe addiction, making it difficult to say with any degree of certainty 
what the true prevalence of addiction is or where the focus for treatment concern should be. 
 
 It was suggested that there had been a change in focus from concentrating only on the 
"cone-dwellers" whose outcome was likely to be generally unfavourable, to trying to identify 
and treat the "slope-climbers" where treatment effectiveness is considerably more optimistic. 
The involvement of the General Practitioner to identify and treat the alcohol and nicotine 
abusers was underway, and studies showed that "quality time" spent by non-specialists with 
these people was just as effective as time spent in expensive special purpose clinics. 
 
 The pattern with illegal abusers was similar, except that they tend to have no General 
Practitioner(GP). Nevertheless, the setting up of Community Drug Teams has been attempted 
in many parts of the U.K., and has proved to be successful by reaching the earlier stage 
problem drug takers while they were still "on the slopes". Outcomes seemed more successful 
at this stage in the case of problem drinkers. Mortality rate was 2 to 4 times less in problem 
drinkers identified and treated by GPs, compared to controls, in one Scandinavian study. So 
treating slope climbers rather than cone-dwellers was effective in reducing mortality also. 
 
 Use of a Community Reinforcement Approach for the more severely affected, in 
which considerable aftercare support is offered, was viewed to be a successful way of 
reducing relapse, but much more study was necessary to confirm this. In discussion it 
became apparent that this approach was supported by anecdotal evidence based on the Hong 
Kong experience. 
 
 Dr. Drummond reported barriers to help-seeking as being a significant factor in 
limiting treatment effectiveness. Even if treatments were effective, it is clear that only a 
minority (around 10% in the case of severe alcohol problems) avail themselves of such help. 
Factors which have been identified include: 
 
 a) Difficulty in knowing where to ask for help. 
 b) Access to the help agency was difficult 
 c) Some people resisted being labelled as an addict. 
 d) Some people feared hospitals, especially psychiatric hospitals. 
 e) Women experienced particular difficulties in seeking help. 
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 The concepts of safe and harmful drinking were discussed. In reference to other 
drugs, the same problem arose, and while some could even use heroin casually, others were 
quickly clinically dependent. This was hotly disputed in discussion, the dispute centring on 
the importance of dependence as a limiting factor in recovery. 
 
 
Conclusions  
 
 It was concluded that future research efforts should best be directed towards getting 
more people into treatment earlier and in helping the greatest number of those in need. 
Making existing services function more effectively should necessarily involve establishing 
through research the most appropriate treatment for the individual and a shift in emphasis 
from the most severely affected to include those at an earlier stage in their drug taking career. 
There is a tremendous untapped resource of generalists who have been shown to be effective 
in treating addictions. It will be necessary to find a method in which specialists and 
generalists can effectively work in partnership. 
 The following points and suggestions for further research were raised in discussion: 
 
a)  Cost/benefit analysis of different kinds of treatment for abusers at different 
stages of experience should be undertaken. 
 
b)  Evidence was gained in relation to the level of severity of addiction in relation 
to the  success of different levels of treatment. 
 
c)  The effectiveness of general help versus specialised help needed to be 
evaluated, particularly in view of the lower cost and greater availability of 
generalists. 
 
d)  The matching of treatment programmes to individual needs requires greater 
research. 
 
e)  The nature and needs of slope-climbers cannot necessarily by inferred from 
the observation  of cone-dwellers. 
 
f)  The long term effects of methadone maintenance on quality of life was 
assessed, especially in relation to its appropriateness for young abusers. 
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g)  Reasons for self-recovery from long term addictions over 10-15 years were 
studied and more research was needed to identify key elements in successful 
recovery from addiction, rather than concentrating on reasons for relapse. 
 
h)  There was a general consensus regarding the importance of programmes 
which responded flexibly to individual patients, and which took account of 
recent research evidence. 
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EPIDEMIOLOGY OF DRUG ADDICTIONS 
MONDAY 7TH, OCTOBER 1991. 
 
 
 The second seminar in the series heard Dr. Drummond of the National Addiction 
Centre speak of his work and that of other international groups on the epidemiology of drug 
addictions. 
 
 Dr. Drummond asserted that questions were often asked of epidemiologists 
concerning the value of their work. He suggested that, in common with other medical 
specialities, work with addictions had begun with attempts at treatment, but that it had been 
realised only after a long struggle that the application of epidemiology was necessary to 
assess the extent and nature of the problems faced by treatment services and to evaluate the 
impact on problems related to substance misuse of public health measures. 
 
1) Epidemiology has led to an understanding of the true scale of the problem which was 
often distorted by the perceptions of those concerned with treatment and 
rehabilitation, because those individuals seen in the treatment setting were not 
necessarily representative of the greater population experiencing problems with a 
substance. 
 
2) Epidemiological studies could give good measures of the effectiveness of an 
intervention to reduce the epidemic of a particular substance's use. e.g. the effects of 
taxation in reduction of tobacco or alcohol use had been monitored by 
epidemiologists. 
 
4) There were valuable potentials for cross-cultural comparisons through 
epidemiological research. This might be particularly important in a country such as 
Hong Kong because affluence and modernisation were leading to changes in 
substance abuse patterns locally, whilst non-Chinese immigrants were affected by 
cultural trends here. Thus in dealing with the whole problem, cross-cultural concerns 
were necessary. 
 
  Hence there was a demonstrable need for good epidemiological research. 
 
 The statistics available for alcohol were considerably better than that for illicit drug 
misuse, because collection of these had been long-standing, and surveys were less 
threatening to respondents as alcohol is a legal substance. Further, in a given country it is 
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possible to obtain accurate figures of total alcohol consumption for that population over a 
given time, whereas the same clearly could not be said for illicit drugs. 
 
 In Hong Kong, the effective data collection of the Central Registry on Drug Abuse 
provides evidence concerning the behaviour of those who had come to the notice of reporting 
agencies, i.e. those who were already addicts; but the epidemiology of non-opiate abuse and 
the behaviour of those not in contact with treatment agencies could not be ascertained from 
this source. As suggested in the previous seminar, these groups are of as much concern to 
helping agencies as those in contact with treatment. 
 
 Considering the possibilities of epidemiological research in substance-abuse, the type 
of work was directly related to its cost, but work at a variety of levels was necessary to 
obtain as complete a picture as possible. 
 
 Lowest costs were attached to studies of existing official statistics. However, these 
presented difficulties of comparability, validity and accuracy. Even mortality statistics are 
unreliable since substance abuse is often not recognised as a factor contributing to death. 
Commercial statistics such as alcohol imports are associated with a degree of error which 
tends not to vary markedly over time, but statistics based on human agencies such as police 
or social workers might vary as agency behaviour towards clients changed from time to time 
(e.g. police arrest policies in relation to cannabis users, or for possession of equipment for 
injection may vary from city to city and from year to year, worldwide). Real outcomes of 
such policy or behaviour change might be felt only after a variable period of time, so that lag 
effects were unpredictable. 
 
 Official data can be biased by political or other motives, so it was important to obtain 
the original figures if possible, and to avoid derived material. 
 
 Studies of registers of admissions to treatment agencies, hospitals etc. could yield 
useful information, but were more expensive to conduct than research using public record 
office statistics. They suffer from the same shortcomings, however. There is the added 
problem that the number or type of individual presenting for treatment may bear little 
relation to the wider population of drug takers. Changes in clinic policy may affect 
prevalence estimates based on such statistics. Further, doctors in general hospitals may be 
reluctant to record the fact of substance abuse in a patient presenting with a medical problem 
because of a stigma attached to such behaviours. 
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 Registers are representative only of those presenting for treatment, or being reported 
for a condition. Those who do not divulge their substance use, or fail to come to the notice of 
a registration agency are however not included in such data. Such data therefore provide only 
a rough approximation of activity in the community. 
 
 Lag phases exist in all registers due to delay in presentation to the reporting agency. 
H.I.V. and smoking were examples where a long lag phase, up to 10 years in the case of 
H.I.V. and 30 years in the case of smoking, might intercede between onset and disease. 
 
 Screening of those at high risk from the activity being studied was a valuable 
investigatory activity. In the case of substance-abuse overdoses, or of substance-abuse 
related accidents, hospital accident and emergency ward studies and medical ward studies 
yielded valuable insights, Blood screening for prevalence have yielded valuable results. 
 
 Nomination studies where a known addict was asked to identify other addicts or 
research which involved the employment of addicts as investigators gave greater reliability 
than simple self-reported anonymous questionnaires. There was potential here for interview 
studies of a non-threatening nature, where members of the sub-culture acted as interviewers. 
 
 Large, general population surveys were expensive to carry out, and without costly 
interviewing techniques, were of suspect validity. An example in Hong Kong is the general 
household survey about youth tobacco use which shows a prevalence of 4% whilst local 
anonymous self-reporting surveys show up to 25% in the same age groups. Elsewhere, 
alcohol surveys had shown that heavy drinkers tend to underestimate their consumption in 
comparison to moderate and light drinkers, thus questioning the validity of such data. Such 
studies are of value, however, particularly in observing longitudinal trends, but one must 
assume a constant error in reporting. 
 
 The value of epidemiology beyond the mere counting of heads was then illustrated. 
Clinicians and epidemiologists differ in seeing two worlds of drug problems: 
 
(i)  Clinic attenders tend to be severely deteriorated people, giving a particular 
view of their problems. 
 
(ii)  Epidemiologists on the other hand identify mainly transient, less severely 
problematic individuals. 
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 It was important to understand how these different perspectives could lead to a very 
different view of the nature of the problems within a population. 
 
 A biaxial view of addiction was offered which led to alternative models of alcohol 
problems and provided a means of understanding the discrepancy in view between these two 
reporting agencies. 
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Figure 1. 
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 This model posits that it is possible to experience problems related to a substance 
without necessarily experiencing a significant degree of dependence. Those who are 
dependent will most likely experience problems related to their use of a substance, such as 
marital, social or police problems. But it is possible to be dependent on a drug without 
experiencing severe problems. An example might include the therapeutic use of nicotine 
chewing gum in smoking cessation. Thus epidemiologists and clinicians may be 
investigating two different groups who vary along these two dimensions. The epidemiologist, 
identifying mainly the non-dependent problem drinker, and the clinician, principally the 
dependent drinker who also experiences significant problems. The different nature of these 
two phenomena could account for differences in attitude between these two professional 
groups as to the needed remedy for the problem. 
 
 Dr. Drummond then presented some data obtained from two clinical populations of 
problem drinkers (in U.K. and Germany) and a general population survey from the U.S. All 
the studies presented support the view that rather than being completely independent, 
dependence and problems are highly correlated with one another. He suggested that it was 
the individual's degree of dependence rather than the amount of alcohol consumed per se 
which determined the extent of drinking problems. The implication is that the altered drive 
state occasioned by dependence and which leads the drinker into a pattern of drinking 
designed to maintain a high blood alcohol level is likely to lead the drinker into offending 
against the prevailing social norms concerning drinking behaviour. 
 
 While this finding was in itself of interest, the data was presented to illustrate two 
important general points: 
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 1)  That studying a phenomenon in different population groups (clinical and 
general) and in different countries (U.K., U.S. and Germany) adds greater 
weight to the findings, and can lead to the discovery of findings which would 
not have been possible had only one population group been studied. 
 
2)  That until clinicians and epidemiologists begin to examine the evidence from 
each other's survey research one cannot be certain whether they are referring 
to the same phenomena when they use the terms 'addiction' and alcohol or 
drug 'problems'. 
 
 In sum, epidemiological research has made a major contribution to our understanding 
of the nature and prevalence of substance-related problems and will continue to be an 
essential tool in planning methods of intervention and in assessing their impact on a 
community. Without epidemiological research the implementation of public health measures 
will be based on at best, guesswork. 
 
 
Questions & Comments 
 
 Dr. Hind: Treatment agencies tend to report long term recidivist addicts, while law 
enforcement agencies are more likely to report beginning addicts. 
 
 Dr. Drummond: Agreed and said that this supported the 'two views' model of attitudes 
to addiction referred to above. 
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CHEMICAL INTERVENTIONS IN ADDICTIONS 
WEDNESDAY, 9TH OCTOBER 1991. 
 
 
 Dr. Drummond introduced the topic as a personal view of the field and opportunities 
for the pharmacological treatment of addiction. He described three areas of opportunity for 
such a use of drugs, firstly in treating the 'addiction' itself, secondly in treating withdrawal 
symptoms, and thirdly in treating the complications which arose from substance abuse. This 
latter use of drug-treatments had been least investigated. 
 
 In general in Hong Kong, it seemed likely that opportunities for research  in this area  
might come only within the context of research on other types of interventions and their 
outcomes. There were problems in pure pharmacological research in that they can be rather 
narrow in focus, relating only to the addiction, rather than the psychosocial issues of the 
condition. 
 
 It was possible to do valuable work at the cellular level, and into conditioning 
mechanisms at the receptor level. Such research has made many advances but much 
remained to be known, for instance it was unclear whether different drugs had different 
effects on receptors, or whether there were specific receptors for different drugs. Neither was 
it clear as to how much commonality existed between different substances. 
 
 There were large programmes in the United States and elsewhere, looking at these 
matters; however trials were very difficult to conduct, drug abusing subjects were inherently 
difficult to study and cross addiction contamination was a constant hazard to  research. 
Subjectivity was always a hazard and costs were very high. 
 
Treating the addiction itself 
 
 In the area of chemical interventions there were many historic studies, indeed the 
story of Heroin itself was based in the search for a non-addictive opioid! There must always 
be suspicions when interventions were attempted using a drug of the same class as that to 
which the subjects are already addicted. 
 
  There were many cases where alternative treatment had themselves become abused 
{e.g. Temgesic (Buprenorphine) and Temazepam in Scotland, Methadone in USA and Hong 
Kong.} 
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 In alcohol research Disulfiram had been used as a sensitising agent, resulting in 
nausea and vomiting if alcohol is taken in conjunction with a therapeutic dose. Calcium 
Carbimide has been used in a similar way. In a one year follow up study no difference in 
abstinence or adjustment was shown between a placebo group of alcoholics and those being 
given Disulfiram in a large multi-centre U.S. study. It seems likely that reinforcement of 
abstinent behaviour may be the effective ingredient rather than the drug itself.  
 
 Research into opioid antagonists had been carried out. Naloxone, having a double 
effect of agonist and antagonist had been tried, together with Naltrexone, a closely related 
compound. The first had led to serious withdrawal discomfort, the second, longer acting, had 
shown some promise. It blocks the "high" of heroin use, so providing a potential in 
preventing relapse. 
 
 Naltrexone has certain undesirable side effects in a number of patients which may 
limit its general use, and clearly needs to be taken indefinitely. The patient can be treated by 
a loading dose of 100mg naltrexone, then giving a daily 25mg dose. 
 
 One study showed that, with a large dose of clonidine and tranquillizers to remove 
withdrawal symptoms, and blocking with naltrexone, patients may be rendered heroin-free in 
as little as 48 to 72 hours. This study awaits replication however. In one study, only 17% of 
patients remained drug-free for more than 90 days on naltrexone. 
 
 Studies on cocaine dependency treatment with bromocriptine and amantadine have 
not proved very successful so far. 
 Work with Buspirone for benzodiazepine dependency had shown some promise. The 
use of haloperidol, which blocks dopamine which may reinforce nicotine dependence had not 
proved effective. 
 
 The use of 5-HT3 antagonists such as Ondansetron in alcohol dependence has shown 
some promise at the Addiction Research Foundation in Canada. 
 
 
Chemical Interventions in Withdrawal 
 
 The range of possible withdrawal treatment varies from no intervention, (cold turkey) 
which is well thought of by some workers, especially if accompanied by intensive personal 
intervention or counselling. However, most professionals involved in the field would regard 
such an approach as leading to excessive and unnecessary discomfort.  
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 The role of methadone in heroin withdrawal is well known, but research shows that it 
is often incorrectly used. Often peak withdrawal from the heroin occurs after the methadone 
has been stopped. There is room for work to improve treatments by varying the dose and 
time of prescription. Up to 3 weeks may be the optimum time for withdrawal from heroin 
through gradually reducing doses of methadone. 
 
 It is also reported that, if the patient enters methadone maintenance, then the 
withdrawal from methadone is often more prolonged than heroin withdrawal itself. 
 
 Treatments using sedatives instead of methadone for heroin withdrawal have been 
tried. Even alcohol substitution has been attempted. Clonidine, which blocks noradrenaline 
release has been used, but agitation and sleep loss, characteristic of opiate withdrawal are 
still seen even though pain is reduced. 
 
 Some recent use of short term benzodiazepines instead of methadone has shown 
positive results. A trial with methadone versus chlordiazepoxide at doses of 300-400 mg of 
chlordiazepoxide per day in a double-blind design led to interesting findings, where, with the 
combined chlordiazepoxide treatment, peak withdrawal came in the first day, whilst 
methadone alone showed the well known long withdrawal period with a lower peak of 
symptoms. This presents the possibility that a short period of detoxification could be 
preferable in terms of patient retention. 
 
 Definition of success in clinical trials such as these is difficult. Physicians may prefer 
to treat withdrawal as an illness and wish to use medication, others may prefer to think of the 
problem as a behavioural one and wish to alter the behaviour, and avoid substitution of one 
habit by another. 
 
 Work with neuro-electrical stimulation (N.E.T.) as preferred by Dr. Schmidt, 
(present) had been subjected to only one randomised clinical trial which showed that those 
receiving N.E.T. had significantly more withdrawal distress than those on a methadone 
withdrawal regimen, however two major studies were at present in progress in America. A 
major problem with N.E.T. for research was that "blind" studies were impossible. Research 
on use of N.E.T. with obstetric pain  was proving to be useful. However, the question of 
whether it would be helpful in opiate withdrawal is not at present supported by the evidence. 
 
 All medication studies were complicated by the beliefs and attitudes of addicts 
towards such treatments, and by the placebo effect, or by expectations of the addict that 
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treatment would lead to cure, and disappointment or anger on suffering symptoms from a 
trial. Addicts were therefore often reluctant to be research subjects. 
 
 
Treating the complications 
 
 The third area was that of treating the consequences of addiction rather than the 
addiction itself. There were several examples where this has been tried. Antidepressants were 
often used to treat depressive illness associated with addiction. The same is the case for 
tranquillizers and anxiety disorders related to addiction. It is often the case, however, that 
such disorders subside without recourse to medication when the individual stops taking the 
addictive drug. There was a danger, then, in advocating the widespread use of such 
medication to treat affective disorders in people who continue to misuse substances. There is 
also an important place for the use of these drugs in an important minority of cases. 
 
 Liver disease represents a significant problem amongst alcohol misusers. There have 
been no major breakthroughs in this area through pharmacological agents, but liver 
transplantation is becoming more commonplace. 
 
There is as yet no effective treatment for H.I.V. infection and prevention remains the 
principal public health approach. 
 
 
Conclusion 
 
 Chemical interventions research was expensive and difficult to carry out without 
extensive facilities. It required specialised units adequately to conduct such studies. 
However, there were promising lines opening up. 
 
Questions 
 
 Dr. Schmidt: What research was there to compare the effects of oral versus injected 
methadone? 
 
 Dr. Drummond: No study had been done, but a study showed that compliance with 
prescribed heroin treatment was better than with prescribed methadone, however, heroin 
recipients tended to be more chaotic in their lives, while the lives of methadone patients 
tended to be more orderly and effective. 
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 Dr. Drummond went on to say that the low H.I.V. incidence here had not brought 
about the need, felt elsewhere, to bring addicts into contact with treatment. That only about 
one-fifth of such addicts were in contact at any time was not a healthy sign if H.I.V. gained a 
more aggressive hold as appeared to be likely. When H.I.V. becomes a priority concern, 
addictions treatments or opportunities for contact were offered on the addicts' terms to bring 
them to counselling  and to try to alter their life-styles to reduce the chances of H.I.V. spread.
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PREVENTION 
FRIDAY 11th OCTOBER 1991. 
 
 
 The aim of this seminar was to describe recent preventive efforts aimed at H.I.V. 
infection in injecting drug misusers in the U.K., as this represented an key area of current 
concern and one which through earlier discussion had emerged as one of interest to several 
seminar attendees. 
 
 In the previous seminar on chemical treatments, Dr. Drummond had alluded to the 
change in attitudes of caring professionals towards controlled prescription of abused 
substances which had occurred in response to the need to reduce behaviours likely to cause 
the spread of H.I.V in the United Kingdom.  He went on to detail how these were seen to be 
preventive and how any modality seen to generate greater contact between users and the 
caring professions was now regarded as the primary aim of treatment. 
 
 First, however, more general preventive efforts in the addictions were described to 
place the current trend in a wider perspective. 
 
 
The 'market place' 
 
 The model offered had been termed the 'market place' model. 
Demand and supply were seen as opposite faces of the same coin, to which cost was an 
effective modifier. Purchase and use led to the problems for the client and the prevalence 
within society. 
 
  Supply factors were: production rates, export/import potential, distribution and 
retailing factors. Profit margins controlled supply, and the potential for new markets and the 
brand loyalty of clients modified it. (cf. the tobacco industries' recent targeting of South East 
Asia) 
 
 Demand factors depended on marketing techniques, the target population, the 
attractiveness of the product in terms of ease of use, benefits from use and its disadvantages. 
Regulation of supply and the elasticity of price and income were further modifying variables. 
 
 It was noted that, for adolescents and younger children, there was a special problem 
in that their ability to discriminate in the face of persuasive forces was particularly low, 
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especially if the subject had not been raised by parents or teachers, or discussed amongst 
peers. 
 
 These considerations laid open a number of intervention targets for policy makers and 
health care professionals. 
 
 On the supply side, crop substitution and enforcement controls had been seen to have 
limited impact. Presently, legalisation was being mooted as a supply and a demand control, 
in that if presently illegal substances were legalised, many factors in both supply and demand 
would be modified in one action. Clearly the shortcoming was in the possible uptake of an 
addictive habit by a significant proportion of the population, so that proposed benefits in 
terms of undermining the black market and reducing drug-related crime could easily be 
outweighed by a rapid and costly increase in health and social adverse consequences. This 
debate remains dominated by inspired guesswork and unsubstantiated dogma rather than hard 
evidence. Further there is danger in extrapolating from one epoch in history to another or 
indeed one country to another when parallels are drawn between the past and current drug 
epidemics. 
 
 However, in the light of H.I.V. seroprevalence of 10%  amongst intravenous drug 
users in London, (up to 70% in some parts of the U.K.), it was necessary to try to curtail this 
route of transmission. The argument has been put forward that decriminalizing drug taking, 
but strictly controlling availability, might allow greater opportunities for a marginalised 
group in society to more readily come into contact with health advice and helping agencies. 
This argument is of course highly speculative and such a policy runs a risk of sending the 
wrong message to the population that heroin taking is not such a dangerous activity as once 
believed, so leading to a greater pool potentially at risk of injecting with its attendant risks. 
 
Injecting drug misuse 
 
 Meanwhile injecting drug misuse was a key route for transmission of H.I.V. and led, 
through the unprotected sexual activities of injecting drug misusers to a much increased 
potential for spread into the non drug-using population; since sexual activity, especially in 
the young, is much more common than intravenous drug-use. 
 
 Hong Kong seems to be in danger of assuming that an epidemic spread of H.I.V. will 
not happen on the same scale as in other Asian countries and indeed other parts of the world, 
since present data indicate a low incidence and a slow increase in prevalence. The 
assumption is that needle sharing is low and promiscuity and homosexuality are also low. 
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However, with 8,000 cases of sexually transmitted diseases, other than H.I.V., being treated 
each year in the social hygiene clinics, and with a 20% prevalence of hepatitis B infection, 
(This virus has an identical method of transmission to H.I.V..) such assumptions seem to be 
rather optimistic. However, the ready supply of cheap needles and syringes may mean that 
the prevalence of needle sharing is relatively low and that sharing with a range of partners is 
probably lower than in some other countries where injecting equipment is less available. 
Government statistics show, however, that over 30% of the 60% of addicts who use 
intravenously, have at some time shared needles. 
 
 Since the consequences of H.I.V. infection are considerably more serious than that of 
drug misuse itself it was suggested that H.I.V. transmission reduction should take precedence 
over other treatment aims. 
 
 Thus, the emphasis would be to contact and to try to change the behaviours of 
particularly high risk groups, including injectors, prostitutes and pregnant women engaging 
in H.I.V. risk behaviours.   
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 In order to do this, it becomes necessary to widen the net of prevention services in the 
following areas: 
 
a)  Prisons 
b)  Arrest referral services, i.e. solicitors and social workers attached to police 
stations who advise on injecting behaviours and other matters. 
c)  Probation Officers 
d)  Health Visitors 
e)  General Practitioners 
f)  Outreach projects 
g)  Obstetric services 
 
Goals of Intervention 
 
 The goals can be graded in a hierarchy as follows: 
 
  Providing health education 
Harm Reduction  
   -stop sharing 
   -safer injecting  
   -stop injecting   
Stabilisation 
   -drug maintenance (e.g. methadone) 
Detoxification 
Drug-free Maintenance 
 
 The underlying principle is to work on the drug-user's terms, not those of the health-
care worker. It is necessary to assume that there may be many stages before a drug-free 
lifestyle can be achieved. Of course, for some individuals rapid progress to a drug-free state 
may be appropriate from the outset. The key is negotiating with the individual drug taker 
which requires skill and sensitivity. The principle is 'if you can't be good, be careful'! 
 
 Prescription of a drug is controlled, within limits, initially by the demands of the 
patient so that he is kept in touch with the care agencies and not lost to return to a more 
chaotic and risky life-style through disaffection with the treatment programme. 
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 The harm reduction policy is to 'capture' the client, to retain them in the programme 
and to follow up with a gradation of measures to reduce risk behaviour and so to prevent 
H.I.V. spread. 
 
 The evidence suggests that, whilst intravenous drug users are changing their using 
behaviour to use clean needles and to avoid sharing, their sexual behaviour has not changed 
to the same extent and unprotected sex is still common. 
 
 The development of H.I.V. prevention began originally with needle exchanges. 
These were 'holes in the wall' of a treatment centre where exchange, strictly on a one-for-one 
basis occurred. Now, they have come more into the open so that users can more readily come 
into contact with a health-care professional, but can get an adequate supply of clean needles 
with less overt pressure to detoxify. Many such schemes operate in effect a primary health 
care service in addition to providing clean needles. This is felt to be an important new 
development. 
 
 It has been found that 2/3 of people coming to these exchanges have never before 
been in contact with drug treatment agencies. Of these, 1/3 had never been in contact with 
any agency. Many, including pregnant drug injectors, are not in routine contact with more 
conventional medical services. 
 
 Syringe exchanges have therefore become providers of health care as well as 
counselling and injecting equipment supply. 
 
 Another form of contact has been provided through pharmacies in some areas of the 
U.K. These provide additional needle exchange services. One recent study found that only 
4% have needle disposal without exchange, however, and this could be improved. Further, 
some pharmacists point to financial disincentives in attracting this client group. 
 
Methadone and the Reduction of H.I.V. Transmission 
 
 The increasing prevalence of H.I.V. infection has altered the attitudes towards opiate 
prescribing considerably within the past three years. The change is being evaluated, but there 
is no time to await the results of evaluations. Proceeding on hope is perhaps the best 
description! 
 
 The setting up of out-patient detoxification and day programmes has also become 
more widespread. In the United States, there has been a slower acceptance of the desirability 
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of the change in emphasis towards drug prescribing. There is also considerable reluctance 
there to embrace a harm reduction approach in the form of needle exchange. 
 
 
Determination of the effectiveness and acceptability of changes in programme 
provisions 
 
 There are important research implications here, and Hong Kong may have some 
special problems to tackle. In the U.K. the acceptability of the interviewer to the interviewee 
is an issue. The technique of peer interviewers and 'snowballing' techniques is increasingly 
being used as a means of contacting those not in touch with helping agencies. 
 
  The measurement of hepatitis B prevalence may be useful in providing an index of 
needle sharing activity. Furthermore, it is possible to use venereal disease clinic statistics as 
an index of unprotected sexual behaviour. Anonymous screening for H.I.V. seropositivity is 
also gaining acceptance. 
 
  There may be a need to extend the role of the Central Registry for Drug Abuse to try 
to estimate the prevalence of drug misuse and drug injecting behaviour in those not in 
contact with services. Outreach workers may be able to provide a useful means of gathering 
such data. 
 
 Compulsory H.I.V. testing cannot be advocated since this is likely to drive users 
'underground', but easy access to voluntary testing with appropriate counselling should be 
assured. It is felt that random blood testing, or testing of all blood samples for H.I.V. would 
provide further important data but will be limited by cost. Periodic and regular point 
prevalence studies of this sort could, however, provide a useful means of monitoring trends. 
 
Conclusions 
 
 H.I.V. infection in injecting drug misusers poses a considerable threat to public health 
and deserves to be taken extremely seriously even when current prevalence is low. While the 
implementation of harm reduction policies such as needle exchange and an expansion in 
opiate prescribing is still undergoing evaluation, there is a general consensus that treatment 
approaches based more on the needs and wishes of the drug taker represent a positive step 
forward. Principally, services which attract those not in contact with 'higher threshold' 
agencies (such as intensive, specialised treatment which insist on complete abstinence and 
lengthy programmes) can be seen as providing an ideal method of attracting more people into 
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treatment with the possibility of progressing towards a drug-free life at an earlier stage. This 
can only help to reduce the consequences of drug misuse for the individual and society, 
including, but by no means exclusively, the spread of H.I.V. infection. 
 
 At present, Hong Kong is seen as vulnerable for increase in H.I.V. prevalence 
because contact with users of drugs is low (25% approximately) and the availability of 
trained workers in the field is limited. Further, Hong Kong is a major trading and tourist 
centre with neighbouring countries having high H.I.V seroprevalence. However, at present 
the Territory is an ideal place for prevention work because the seroprevalence remains low. 
Without further action this desirable situation may well change. A harm reduction approach 
should therefore be considered as a vital adjunct to existing intensive 'curative' treatment 
programmes. 
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OPPORTUNITIES FOR ADDICTION RESEARCH IN HONG KONG 
Report on a visit to Hong Kong, October, 1991. 
 
by D. Colin Drummond, M.D., Ch.B, M.R.C.Psych. 
Research Psychiatrist, Addiction Research Unit 
National Addiction Centre, Institute of Psychiatry, 
London, U.K. 
 
 
Introduction 
 
 The establishment of the Drug Addiction Research Unit (DARU) at the University of 
Hong Kong is an important and historic development in the addictions field.  It is important, 
not only for Hong Kong, but also for the international community engaged in the prevention 
and treatment of the problems brought about by the use of psychoactive substances.  I had the 
opportunity to witness and participate in some of these developments in October 1991.  This 
visit was made possible through a grant from the British Council. 
 
 The purpose of my visit was to assist in the development of the DARU by facilitating 
discussion between interested parties and to help in identifying important new research leads, 
relevant both to the particular problems faced by Hong Kong as well as being of wider 
research interest.  My formal programme comprised the facilitation of 4 research seminars, 
meetings with members of university departments, representatives of both Governmental and 
non-governmental organizations, and visits to several treatment agencies. Several 
information meetings, 'after hours', with key actors in the addiction research and treatment 
field helped greatly in forming a broader impression of the Hong Kong situation, as well as 
allowing the development of many new friendships. 
 
 This report represents what must be viewed as only a modest attempt to bring 
together some of the many thoughts and impressions gained during my brief two week visit. 
With the wealth of activities and initiatives in the addictions field in Hong Kong, there is a 
limit to the number of individuals who can be met or centres visited in such a brief period.  
This report does not aim to provide a definitive review of all the activities taking place in 
Hong Kong, nor is it an attempt to impose the arguably ill-informed views of the foreign 
visitor. There are many renowned experts with a wealth of experience of the Hong Kong 
situation who are much more qualified than I to provide such a review. 
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 Hong Kong is indeed fortunate to have such a wealth of interested and experienced 
individuals in this field as well as the strong support of so many organizations, both 
governmental and non-governmental. The aim of this report is to stimulate further activity 
and collaboration in addiction research, building on an already strong base. The newly 
formed DARU provides an ideal focus for such future activity. 
 
 The report is organized into four sections. A brief discussion of addiction problems in 
Hong Kong as seen by the foreign visitor is followed by an overview of existing responses to 
the problems. The potential role of the DARU in future developments is discussed, followed 
by a section exploring the research opportunities in Hong Kong. 
 
 
Addiction Problems in Hong Kong: the changing scene 
 
 It is clear that the largest problem related to the use of psychoactive substances in 
Hong Kong is that of opiate addiction. While the exact size of the affected population is 
unknown, there are estimated to be in excess of 40,000 addicts in Hong Kong (C.R.D.A., 
1990). The prevalence of opiate addiction is clearly considerably higher than in most 
Western countries including the United Kingdom where there are thought to be around 
200,000 opiate addicts in a population of approximately 53 millions. According to the 
Central Registry of Drug Abuse (amongst other sources), however, the scene is changing. 
The proportion of newly reported individuals attending for treatment  who are abusing drugs 
other than opiates (including cannabis, stimulants and benzodiazepines) has increased 
considerably in the last decade. Further, in common with the experience of many Western 
countries, the mean age of the addict population has fallen significantly over the same period. 
Although the proportion of newly reported addicts who inject opiates has fallen recently, 
approximately 60% of reported individuals are injectors. This has particular significance for 
the transmission of infectious diseases (see below). 
 
 Another change in Hong Kong has been the increasing recognition of alcohol and 
tobacco use, particularly in the young. Approximately one third of 14 year-old youths 
surveyed by the Community Drug Advisory Council in 1990 reported taking alcohol more 
than once per month. Further there had been a considerable increase in the regular use of 
tobacco by  those 16 and 17 years old, between 1988 and 1990 (from 14% for each group to 
22% and 19% respectively) (C.D.A.C., 1991). This latter finding is perhaps not surprising in 
view of the highly visible advertising and aggressive marketing policies of the tobacco 
companies in Hong Kong, as well as other parts of South East Asia. 
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 While H.I.V. infection in drug injectors remains low in Hong Kong compared to 
other Asian countries in close proximity and indeed compared to Western countries, the 
potential for an epidemic in Hong Kong is considerable. Three factors in particular place 
Hong Kong at risk for such an epidemic. It is a major trading port which receives many 
visitors from high prevalence areas with respect to H.I.V. each year. Many drug addicts are 
engaged in a lucrative sex industry catering for both Hong Kong residents and visitors. 
Further, as mentioned above, injection is the preferred route of administration of opiates. 
Even with the high availability of sterile injecting equipment and reputedly low rates of 
needle sharing activity, the potential for the spread of H.I.V. in Hong Kong is considerable. 
 
 Taken together, the information already available suggests that the drug scene in 
Hong Kong is changing in such a way as to present new challenges for treatment and 
prevention agencies. 
 
 
The Response 
 
 Hong Kong has a long and internationally distinguished history of treatment and 
rehabilitation initiatives. I had the opportunity to visit only a small sample of all the agencies 
listed in the Directory of Drug Abuse Demand Reduction Programmes and Services (Hong 
Kong Council of Social Services, 1991). But those which I was able to visit represented a 
broad cross-section of those available. According to official sources (Hong Kong Council of 
Social Services, (H.K.C.S.S.), 1991) there are currently approximately 13,200 individuals 
receiving some form of treatment or rehabilitation service each day in Hong Kong: probably 
a much higher proportion of the total drug taking population than in most Western countries. 
 
 i)  The methadone outpatient programme caters daily for 7,207 drug addicts. 
Two things are striking to the U.K. visitor about these programmes. Compared to the 
equivalent centres in the U.K. they have to cope with a considerable larger throughput of 
patients given the staff complement, and second, the emphasis appears to be more in keeping 
with the original American concept of methadone maintenance. Given the recent resurgence 
in interest in maintenance rather than detoxification in Europe in the wake of the H.I.V. 
epidemic, Hong Kong appears somewhat ahead of the trend. If as seems likely, the H.I.V. 
epidemic spreads to Hong Kong the widespread availability of this form of treatment will 
provide an excellent opportunity to investigate methadone maintenance as a public health 
measure. One would hope however that more trained staff could be recruited into this 
service. With just one doctor and one social worker in one busy methadone clinic which I 
visited, to deal with hundreds of registered patients, one wonders how therapies beyond 
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simply the delivery of basic medical and social care can reasonably be delivered even 
without an epidemic of AIDS cases to contend with. In sum while the clinics are a 
tremendous achievement, their popularity compromises their capacity to cope adequately 
without and expansion in trained personnel. 
 
 ii)  In-Patient treatment. There are many such services available under the 
auspices of both Governmental and non-governmental organizations. I was only able to visit 
a small number of these. The services are provided on both a compulsory and voluntary 
basis, although to the outsider the element of compulsion appears much more predominant 
than in the West. Many I spoke to believed that such an approach was essential particularly 
in dealing with type of problem encountered in Hong Kong. While this argument seemed 
persuasive it was somewhat at odds with much of the current Western thinking on flexibility 
of treatment goals (see below). Another striking feature of these services was the relatively 
limited involvement of specialized psychiatric and clinical psychology personnel. 
 
  I understood from several professionals whom I spoke to in these centres that this 
was mainly due to a shortage of such trained individuals and the relative lack of a suitable 
career structure for specialists of all types in the addictions field (a problem which seemed to 
apply equally to the methadone clinics). While many treatment and rehabilitation services 
can operate perfectly well without psychiatrists or psychologists, many I spoke to indicated 
that there was an urgent need for expansion in this area. The establishment of greater training 
opportunities, appropriate incentives, and a more attractive career structure for addiction 
specialists would, I feel, go a long way towards solving this problem. Of course Hong Kong 
is not alone in this difficulty. 
 
 As an additional point, particular concerns were raised by several professionals that I 
met concerning the special provision for substance misusers in the non-Chinese population in 
Hong Kong. I learned that while services catering specifically for the Chinese population 
were fairly widespread and of high quality, difficulty had been often experienced in 
obtaining appropriate help within the public sector for non-Chinese residents. Study of the 
prevalence of problems and demand for services in this group deserves urgent attention. 
 
 iii)  Aftercare services.  Hong Kong appeared particularly strong in its provision 
of facilities of this type. Resettlement, job placement, and support following discharge are 
clearly important elements in successful rehabilitation, an issue not often tackled with the 
same diligence in the U.K.. Again, however, many I spoke to felt that with the number of 
drug addicts undergoing inpatient treatment there was still further room for expansion in the 
provision of aftercare services. 
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 iv)  Drug-free outpatient treatment services.  One of the greatest difference 
between services in Hong Kong and those in the West, is the relative shortage of outpatient 
or day patient services which do not involve the provision of prescribed drugs. Many such 
services have developed in both the U.K. and in the U.S. in recent years. Services in Hong 
Kong, with the exception of the methadone programmes, tend to employ admission as the 
preferred mode of treatment. Two important exceptions to this include St. Stephen's Society 
and the PS33 service run by the Hong Kong Christian Service. Both projects seemed 
particularly exciting and innovative. St. Stephen's Society operates a range of integrated 
services from 'low threshold' outreach work up to residential treatment and aftercare. PS33 
provides a variety of outpatient and other services, although in contrast to the former, they 
are targeted at 'psychotropic substance misusers' (meaning non-opiate misusers). 
 
  To the foreigner it seems somewhat counter-intuitive to separate different classes of 
drug misuse in this way, and in doing so deprive certain 'psychotropic substance misusers' (in 
the form of those who take opiates) from such a valuable service. Experience elsewhere 
suggests that such an artificial segmentation of services inhibits the capacity to respond 
quickly to the changing drug scene. Further, such drug free services seem to be particularly 
effective in attracting opiate and other drug misusers not in convert with 'higher threshold' 
services such as inpatient treatment and methadone clinics. 
 
 v)  Outreach services have become an important development in the West, 
particularly in the wake of H.I.V. Getting more people into treatment earlier has become a 
higher priority than hitherto. In most countries, at any given time, only a small proportion of 
drug misusers are in contact with treatment services. Further it  may take many years of drug 
misuse with ensuing harm to the individual and to society before a drug misuser makes his 
first contact with a treatment agency; it may take many more years of coming in and out of 
contact with services before a lasting positive change in the behaviour is achieved. Services 
have conventionally operated on a similar basis to hospital medical services, in which the 
agency is satisfied to await the individual's presentation for help. In the case of addictive 
disorders however, there is  growing evidence that there is a greater capacity for change than 
was previously believed and that if an individual can be contacted at an early stage in their 
drug taking career, even relatively minimal intervention can have important and lasting 
benefits. 
 
 Outreach has become particularly important as a means of getting important health 
information to those not in contact with services in the prevention of the spread of H.I.V. It 
has also become clear however that outreach work can help to bring drug misusers into 
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contact with not only drug treatment services, but also primary health services. Very few 
such approaches currently operate in Hong Kong, a notable exception being the St. Stephen's 
Society. The expansion of outreach work by both statutory and non-governmental 
organizations should be given serious consideration. Such a development will necessarily 
require a change in treatment philosophy towards being prepared to engage and work with 
individuals who are not able or prepared to consider complete abstinence as a treatment goal. 
 
 vi) Prevention.  There are several important preventive measures which have 
been introduced in Hong Kong. Organizations important in this field include the Action 
Committee Against Narcotics, the Society for the Aid and Rehabilitation of Drug Abusers 
and the Community Drug Advisory Council, to name a few. While this subject will be the 
focus of other reports it is worth making a few observations in the context of the present 
discussion. Prevention is clearly an important objective in view of the difficulty in helping 
the established addict towards a drug free existence. In spite of the best preventive 
programmes, however, there will be individuals who do not respond to such initiatives. 
Further, the evidence concerning the effectiveness of preventive advertising campaigns form 
a wide variety of countries has been disappointing. 
 
 While this does not provide an adequate reason to abandon such efforts there is 
danger in assuming that the extremes of, on the one hand, advertising, and on the other, 
rehabilitation, can adequately address the problems caused by drugs in a community. It 
seems that the most promising area for future work lies in developing a comprehensive range 
of initiatives spanning from the treatment setting into the community and in particular 
reaching those who are beginning to experiment with drugs and those at an early stage of 
their drug taking career. This necessarily requires greater integration of effort of those 
involved in preventive education, treatment, outreach work, and including agencies which 
have not previously seen themselves as having a particular interest in such a preventive role 
but who are nevertheless in personal, and often, daily contact with drug misusers. Such 
agencies will naturally include the police, the Courts, the primary health care physicians, the 
emergency services, teachers, and many others.  Drug misuse is a problem for the whole 
community and requires integration and a common purpose. 
 
 
The Drug Addiction Research Unit 
 
 What should be the role of the DARU within the developing and changing drug scene 
in Hong Kong? 
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 i)  Research   Its first and most important function should be that of research. 
Research in the addiction field is not a mere luxury, to be seen as attracting limited resources 
away from the important and pressing business of treatment and prevention.  Instead it must 
be viewed as and essential adjunct to such efforts. Without the application of independent 
scientific analysis to the problems brought about by drugs society will continue to pour 
considerable, although greatly needed, resources into the problem without a clear 
understanding of the most appropriate way in which it should be spent. Nor should research 
in this field be seen as a bureaucratic exercise in data gathering as can so easily be the case. 
Research must address itself to the important policy issues of the day, and researchers must 
be prepared to ask difficult questions of even the most established and enshrined methods of 
dealing with the problem: research should be seen as an essential means to inform debate and 
to improve our response to the drugs problem. Several crucial issues facing Hong Kong in its 
efforts to deal with the drug problem have been identified in this brief review. What is the 
true scale of the problems related to alcohol, tobacco and other psychoactive drugs?  What 
treatments work best for whom? How do we get more people into treatment earlier? Without 
research, the answer to such questions remains the subject of ill-informed speculation. The 
DARU has a vital role to play in bringing together and providing a resource for the network 
of experts in Hong Kong, many of whom have already carried out important pioneering 
research in this field, as well as attracting young and talented researchers into this important 
area of social concern. 
 
 ii)  Education   The DARU can also provide an essential resource in 
disseminating knowledge. Clearly encouraging new people to enter this research field is an 
important priority. But its educational remit should extend much further. The University of 
Hong Kong already provides first class education in the teaching, psychology, medical and 
social work fields, disciplines which have an important role to play in dealing with the drugs 
problem. The DARU will provide for the first time in Hong Kong, a problem-focused 
department which could bring together tomorrow's addiction treatment and research 
professionals, clearly adding strength and legitimacy to the study and treatment of addiction 
as a worthy area of social and professional concern. But the DARU also has an opportunity 
positively to influence a wider section of society. Staff in the University already disseminate 
knowledge through their contact with the media and in their advisory role in governmental 
and non-governmental organizations. 
As the Unit develops it has the potential to expand this role in such a way as to help in 
increasing public knowledge and awareness of drug related-issues. 
 
 iii) Networking  While there are many individuals and organizations in Hong Kong 
closely involved in dealing with the problems of psychoactive substances, there has been 
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until now no academic establishment to provide a focus for research and training endeavour. 
Earlier in this report the lack of a suitable career structure for many professionals in the 
addictions field was identified as an obstacle to recruitment and retention of skilled workers. 
It was extremely encouraging to witness addiction professionals, who had been working in 
Hong Kong in this field in many cases for several years, meeting other such individuals for 
the first time in the seminars which were held at the University during my visit. The need for 
such a network of support and sharing of experiences between professionals in the field was 
clearly apparent. Further, research ideas rarely crystallize in a setting of isolation. The 
DARU will be a vital catalyst for innovative research in Hong Kong. 
 
 iv) Independence    The status of the DARU as an independent academic group 
is essential to aid in rational policy development in Hong Kong. Research needs to be 
developed independently of vested interest or party politics. The advantage of such a status is 
that while Government or other organizations should be able to approach such a group to 
commission the research of important policy issues, the core research group and ethos of the 
Unit will not be subject to short term fluctuations in policy. Thus longer term work which is 
of more fundamental and of greater international importance than the particular 'flavour of 
the month' problem of today's administration, may be conducted without interruption. 
 
 v) Making International Connections. Research in the addiction field is an 
international activity. There are now several addiction research centres around the world 
which would not only benefit by learning from the Hong Kong experience but which could 
be of potential benefit to Hong Kong. The Unit will be strengthened by establishing a high 
international profile. The will assist in achieving the aim. 
 
 
Research Opportunities 
 
 It was clear during my visit that there was not only considerable interest in the 
development of addiction research in Hong Kong, there were many excellent opportunities 
for innovative projects. In drawing up a potential plan of research it is important to take  into 
account not only the interests and expertise of individuals already working in this field in 
Hong Kong, but also the needs of Hong Kong and the wider international context. What 
follows represents some initial proposals for topic areas which were arrived at through 
discussion during my visit. Clearly, however, any such 'shopping list' must be viewed as very 
preliminary and time bound to one brief period in 1991. Just as the drug scene is continually 
changing, so do the needs of research evolve. Nevertheless, these topic areas are of pervasive 
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and international importance and are unlikely to fade in significance for some time. In listing 
them no particular order of importance is intended. 
 
 i)  Prevention.   The DARU already has considerable expertise in this area 
particularly with respect to research in the school setting. Methods of changing the attitudes 
and behaviour of those experimenting with psychoactive substances including alcohol and 
tobacco as well as illicit drugs will continue to be an important focus for research. Research 
into implementing effective early identification and intervention approaches is much needed. 
 
 ii)  Epidemiology. Basic epidemiological information is needed concerning the 
prevalence of psychoactive substance misuse. One cannot rely solely on data derived from 
clinical populations to assess prevalence. In particular the prevalence of alcohol misuse 
requires investigation. The study of populations not in contact with treatment services will 
also help in the rational planning and implementation of new treatment initiatives. The 
foregoing discussion points to the need for the study of outreach work as a means of early 
intervention as well as using outreach approaches to contact and study drug misusers not in 
contact with helping agencies. 
 
 iii) H.I.V. and drug injecting.   While connected with epidemiological methods, 
H.I.V. is separately identified here as an important topic of research in its own right, given 
the rapid global spread of the disease. With so many injecting drug misusers already in 
contact with services there is an ideal opportunity anonymous screening. Further it would be 
possible to monitor the prevalence of, and changes in, needle sharing activity and other risk 
behaviours and their relationship to treatment experience. 
 
 iv)  The penal system.   Many psychoactive substance misusers come into contact 
with the penal system during the course of their drug taking career. Methods of diverting this 
group from custodial sentences into treatment already exist in Hong Kong. The way in which 
this system currently operates and ways of improving it could usefully be explored. The 
effectiveness of methods of treatment for drug offenders which do not necessarily involve 
lengthy inpatient treatment, particularly in the case of minor offenses or those at an early 
stage in a drug misusing career could usefully be evaluated by the DARU. 
 
 v) Treatment Research.   Large scale clinical studies involving lengthy follow-
up periods are generally expensive and, unless conducted in a randomized  controlled trial 
design, tend to yield little useful information. The DARU will have to decide whether it will 
have sufficient resources to make a large commitment to this area. Opportunities exist, 
however, to study the process of treatment in different treatment settings and to explore the 
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organization and implementation of treatment systems. Such research might include the 
study of the attitudes and behaviour of treatment professionals. As a first step there is a 
pressing need adequately to describe the existing operation of treatment services in Hong 
Kong. Such an analysis must get beyond the level of the official report or service directory 
and explore the treatment philosophies, historical influences and comprehensiveness of 
treatment services, achieving a more qualitative level of analysis. 
 
 It was clear during my visit that there were many treatment and research activities 
taking place in the addictions field in Hong Kong, but no independent or comprehensive 
reference source to which one could refer. Holding up a mirror to treatment services in this 
way could prove invaluable in planning further developments. 
 
 vi) International Collaboration. A number of possible collaborations already 
exist with groups in other countries. Developing links with other research groups through 
such collaboration will strengthen the DARU's experience and standing. Clearly one will 
need to be selective in such activities: there is a limit to what can be done by one research 
group, and what may be of interest to one country may be of little or no relevance to the 
Hong Kong situation. I am sure that several research units would also be interested in such 
collaboration, including the National Addiction Centre in London. 
 
Conclusions 
 
 The establishment of the DARU is an important event for Hong Kong. Such a 
development is particularly timely in the context of a changing drug scene and the new 
challenges which this presents for agencies trying to deal with the enormous and costly 
problems brought about through addiction to psychoactive substances. There are many 
excellent opportunities for addiction research in Hong Kong and, from what I have witnessed 
during my brief visit, a wealth of expertise amongst professionals in the field as well as 
considerable goodwill expertise amongst professionals in the field as well as considerable 
goodwill and keenness to establish this vital focus for academic endeavour. 
 
 What is now needed is funding support to expand the DARU to a capacity where is 
can reasonably make an impact on the problems faced by Hong Kong. Throughout this report 
areas have been identified where the DARU, given appropriate support, could help in 
combatting the problems of psychoactive substance misuse, through research, education, 
training, and in advising rational policy making. The way in which the DARU could benefit 
Hong Kong by building on an already strong base of expertise is clear. Without such an 
important research initiative Hong Kong will miss the opportunity to capitalize on valuable 
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existing human resources in this field and will have to rely on policy making by trial and 
error. 
 
 I wish the DARU every success in its endeavour. You can be assured of the 
continuing willingness of myself and my colleagues in London to provide advice and support 
in any way possible. 
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